CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

BTB1 100mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTB1 1mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTB1 50mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTR-1 5mg  | ≥98%

CSNpharm

BTR-1 is a rhodanine derivative induced cytotoxicity in a time- and concentration-dependent manner on leukemic cell line, leading to increased level of ROS production and DNA strand breaks suggesting activation of apoptosis for induction of cell death.

More Information Supplier Page

BTR-1 10mg  | ≥98%

CSNpharm

BTR-1 is a rhodanine derivative induced cytotoxicity in a time- and concentration-dependent manner on leukemic cell line, leading to increased level of ROS production and DNA strand breaks suggesting activation of apoptosis for induction of cell death.

More Information Supplier Page

BTR-1 100mg  | ≥98%

CSNpharm

BTR-1 is a rhodanine derivative induced cytotoxicity in a time- and concentration-dependent manner on leukemic cell line, leading to increased level of ROS production and DNA strand breaks suggesting activation of apoptosis for induction of cell death.

More Information Supplier Page

BTR-1 50mg  | ≥98%

CSNpharm

BTR-1 is a rhodanine derivative induced cytotoxicity in a time- and concentration-dependent manner on leukemic cell line, leading to increased level of ROS production and DNA strand breaks suggesting activation of apoptosis for induction of cell death.

More Information Supplier Page

BTS 250mg  | ≥99%

CSNpharm

BTS is a potent and selective inhibitor of Ca2+-stimulated myosin S1 ATPase with IC50 value of ~5 µM.

More Information Supplier Page

BTS 50mg  | ≥99%

CSNpharm

BTS is a potent and selective inhibitor of Ca2+-stimulated myosin S1 ATPase with IC50 value of ~5 µM.

More Information Supplier Page

Bufalin 10mg  | ≥99%

CSNpharm

Bufalin a major digoxin-like immunoreactive component of the Chinese medicine Chan Su and has been shown to exert a potential for anticancer activity against various human cancer cell lines in vitro.

More Information Supplier Page

Bufalin 5mg  | ≥99%

CSNpharm

Bufalin a major digoxin-like immunoreactive component of the Chinese medicine Chan Su and has been shown to exert a potential for anticancer activity against various human cancer cell lines in vitro.

More Information Supplier Page

Buparvaquone 100mg  | ≥98%

CSNpharm

Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone and it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.

More Information Supplier Page

Buparvaquone 50mg  | ≥98%

CSNpharm

Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone and it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.

More Information Supplier Page

Buparvaquone 10mg  | ≥98%

CSNpharm

Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone and it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.

More Information Supplier Page